MTM-CNM Family Connection
  • Home
  • About
    • About MTM/CNM
    • About Us
    • Contact
    • Newsletters
    • Traveling Turtle
  • Family Conference
    • 2019
    • Previous Conferences >
      • 2017
      • 2015
      • 2013
      • 2011
      • 2009
  • Resources
  • Research
    • Research Studies
    • Drug Approval Overview
    • Selected Publications
  • Fundraising
  • Blog
Picture

Thank you for joining our recent Community Conversations webinar...

Picture

Learn about our advocacy for patient engagement in drug development:

Picture

Myotubular & Centronuclear Myopathy
Externally-Led Patient-Focused Drug Development (PFDD)
Virtual Meeting


​August 3rd, 2021
10:00 am EDT-3:00 pm EDT

The recording of this live event is now available for replay on-demand!  Click below, or use the Zoom link that you received if you already registered.
Click Here to Watch On-Demand
What is an "Externally-led Patient Focused Drug Development (PFDD) Meeting"?

The FDA states, “Patient-focused drug development is a systematic approach to help ensure that patients’ experiences, perspectives, needs, and priorities are captured and meaningfully incorporated into drug development and evaluation. As experts in what it is like to live with their conditions, patients are uniquely positioned to inform the understanding of the therapeutic context for drug development and evaluation”. 

So, a PFDD meeting is a platform for the patient community to share the stories of how their lives are impacted by the disease and their hopes and priorities when it comes to any potential therapies.

A PFDD meeting is not specific to any drug and therapy but rather a moment to hear the patient voice on the disease impact and what meaningful improvement looks like from the patient and caregiver perspective.

("Externally-led" means that the meeting is being run by the patient community rather than being hosted by the FDA.)
Agenda (all times Eastern)
10:00  Welcome & Introductions

 
10:10  Opening Remarks, Representative of the FDA
 
10:30 Overview of X-Linked Myotubular Myopathy & Centronuclear Myopathy 
 
11:00 Patient & Family Voice Panel Topic 1: Impact of MTM & CNM
 
12:00 Current Therapeutic strategies for MTM & CNM
 
12:30-1:00 Lunch Break
 
1:00 Patient & Family Voice Panel Topic 2: Meaningful Outcomes
 
2:00 Patient Preferences & Risk/Benefit Considerations
 
2:30 Meeting Summary and Closing Remarks

Thank you for your interest in this important event!

This PFDD is Co-Hosted and Moderated by the following MTM-CNM Patient Advocacy Organizations:
Picture
Picture


We had a great time at the 2019 MTM-CNM Family Conference!
July 19-21, S
t. Louis MO

Picture

Celebrating a decade of connections!

Picture
Photo Credits: Sergio Vazquez
Picture
Tweets by MTMCNMFamily
Picture
Copyright 2014-2022 MTM-CNM Family Connection, Inc 
Admin
  • Home
  • About
    • About MTM/CNM
    • About Us
    • Contact
    • Newsletters
    • Traveling Turtle
  • Family Conference
    • 2019
    • Previous Conferences >
      • 2017
      • 2015
      • 2013
      • 2011
      • 2009
  • Resources
  • Research
    • Research Studies
    • Drug Approval Overview
    • Selected Publications
  • Fundraising
  • Blog